The Enterprise Value as of December 2025 (TTM) for Bio-Gene Technology Limited (BGT.AX) is 6.84M

According to Bio-Gene Technology Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 6.84M. This represents a change of 4.78% compared to the average of 6.53M of the last 4 quarters.

Bio-Gene Technology Limited (BGT.AX) Historical Enterprise Value (quarterly & annually)

How has BGT.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Bio-Gene Technology Limited over the last ten years is 12.27M. The current 6.84M Enterprise Value has changed 5.48% with respect to the historical average. Over the past ten years (40 quarters), BGT.AX's Enterprise Value was at its highest in in the December 2021 quarter at 29.22M. The Enterprise Value was at its lowest in in the December 2013 quarter at 0.

Bio-Gene Technology Limited (BGT.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Bio-Gene Technology Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Bio-Gene Technology Limited (BGT.AX) Average Enterprise Value

How has BGT.AX Enterprise Value performed in the past?

The current Enterprise Value of Bio-Gene Technology Limited (BGT.AX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Bio-Gene Technology Limited (BGT.AX) Enterprise Value vs. Peers

How is BGT.AX’s Enterprise Value compared to its peers?

Bio-Gene Technology Limited’s Enterprise Value is greater than Invex Therapeutics Ltd (3.64M), greater than Vectus Biosystems Limited (5.82M), greater than Intelicare Holdings Limited (0), less than Memphasys Limited (14.63M), greater than Percheron Therapeutics Limited (-2529928.00), less than Acrux Limited (9.34M), greater than Biotron Limited (4.05M), less than Chimeric Therapeutics Limited (6.99M), greater than InhaleRx Limited (5.34M), less than Cann Group Limited (81.46M),

Build a custom stock screener for Bio-Gene Technology Limited (BGT.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Bio-Gene Technology Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Bio-Gene Technology Limited (BGT.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Bio-Gene Technology Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.